Skip to content
Review Open access

Case report: vitreous hemorrhage after thrombolysis in a patient with acute ischemic stroke

Oct 2026 · ANPAbstract_CBN26 · 0 citations

Abstract

Case Presentation: An 83-year-old man presented with sudden onset of left-sided weakness beginning at 2:00 PM. His medical history included hypertension, diabetes mellitus, and dyslipidemia. Neurological examination revealed left-sided anosognosia, tactile and visual extinction, left hemianopsia, right gaze preference, left central facial palsy, disproportionate hemiparesis with left brachiofacial predominance, left hypoesthesia. Plantar response was flexor on the right and extensor on the left (NIHSS score: 15). Non-contrast head CT performed at 16:30 showed an ASPECTS score of 10. CT angiography of the head and neck demonstrated an atherosclerotic plaque in the right internal carotid artery without large-vessel occlusion and diffuse intracranial stenoses. Given the suspicion of a right total anterior circulation stroke (TACS) involving the middle cerebral artery (MCA) within the therapeutic window, intravenous thrombolysis with alteplase was administered at 16:54 (0.9 mg/kg; body weight 58 kg). A follow-up head CT performed on February 26 revealed a vitreous hemorrhage in the left eye that had not been present on the initial imaging. Discussion: This case describes a rare post-thrombolysis complication that has been scarcely reported in the literature. To date, only one case report published in 2019 has described intraocular hemorrhage occurring in a stroke patient after completion of reperfusion therapy with tPA. A 2025 systematic review identified four cases in which thrombolytic treatment for retinal artery occlusion resulted in intraocular hemorrhage. In the same study, an additional 12 cases of intraocular hemorrhage were reported following thrombolysis for other indications. Several causes of visual impairment should be considered in patients with acute stroke, including visual field defects caused by the stroke itself, hemorrhagic transformation affecting the visual pathways, increased intracranial pressure with papilledema, and carotid occlusion causing central retinal artery or ophthalmic artery occlusion. In this case, careful neuro-ophthalmologic evaluation led to the diagnosis of proliferative diabetic retinopathy. The most plausible pathophysiological mechanism is rupture of fragile retinal neovessels associated with proliferative diabetic retinopathy after systemic thrombolysis. Computed tomography also played an important role in this case, as significant vitreous hemorrhage can appear as hyperdensity within the vitreous cavity, potentially aiding early detection. Final Comments: Although rarely reported, hemorrhages at unusual sites, such as the eye, may occur after thrombolysis. Awareness of this potential complication and early recognition may allow prompt management and help prevent irreversible visual impairment.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.